Home/Filings/4/0001871615-25-000008
4//SEC Filing

Freeman Chris 4

Accession 0001871615-25-000008

CIK 0001576280other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 9:37 PM ET

Size

23.7 KB

Accession

0001871615-25-000008

Insider Transaction Report

Form 4
Period: 2025-12-05
Freeman Chris
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2025-12-05$101.43/sh478$48,48256,961 total
  • Sale

    Common Stock

    2025-12-05$102.31/sh744$76,11656,217 total
  • Sale

    Common Stock

    2025-12-05$103.48/sh372$38,49555,845 total
  • Sale

    Common Stock

    2025-12-05$104.10/sh244$25,40055,601 total
  • Sale

    Common Stock

    2025-12-05$106.63/sh228$24,31255,373 total
  • Sale

    Common Stock

    2025-12-05$101.40/sh4,084$414,12951,289 total
  • Sale

    Common Stock

    2025-12-05$102.09/sh11,969$1,221,97039,320 total
  • Sale

    Common Stock

    2025-12-05$103.25/sh3,414$352,50535,906 total
  • Sale

    Common Stock

    2025-12-05$103.97/sh6,555$681,53429,351 total
  • Sale

    Common Stock

    2025-12-05$105.99/sh400$42,39528,951 total
  • Sale

    Common Stock

    2025-12-05$106.71/sh2,964$316,28325,987 total
Footnotes (11)
  • [F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.770 to $101.750. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F10]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.415 to $106.390. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F11]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.500 to $106.990. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F2]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.810 to $102.700. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.005 to $103.860. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.010 to $104.200. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F5]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.450 to $106.735. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F6]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.710 to $101.695. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F7]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.720 to $102.700. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F8]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $102.720 to $103.710. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F9]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.725 to $104.510. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Issuer

Guardant Health, Inc.

CIK 0001576280

Entity typeother

Related Parties

1
  • filerCIK 0001871615

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 9:37 PM ET
Size
23.7 KB